Literature DB >> 31911824

Corrigendum to "Serum Procalcitonin Levels in Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion".

Yosuke Fujii1,2, Masato Yashiro2, Mutsuko Yamada2, Tomonobu Kikkawa2, Nobuyuki Nosaka2,3, Yukie Saito2, Kohei Tsukahara3, Masanori Ikeda1,2, Tsuneo Morishima2, Hirokazu Tsukahara2.   

Abstract

[This corrects the article DOI: 10.1155/2018/2380179.].
Copyright © 2019 Yosuke Fujii et al.

Entities:  

Year:  2019        PMID: 31911824      PMCID: PMC6930740          DOI: 10.1155/2019/4025694

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


In the article titled “Serum Procalcitonin Levels in Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion” [1], there are errors that should be updated as follows: In Abstract, (p = 0 0006) should be (p = 0.0011), (p = 0 94) should be (p = 0.21), and (79% and 100%) should be (100% and 80%) In Section 3.2 in Results, “a sensitivity of 79% and a specificity of 100%” should be “a sensitivity of 100% and specificity of 80%” The figures' and tables' captions are incomplete. They should be updated as follows: Figure 1 PCT/CRP ratio in each disease group. AESD: acute encephalopathy with biphasic seizures and late reduced diffusion; CRP: C-reactive protein; FS: febrile seizures; PCT: procalcitonin; SIRS: systemic inflammatory response syndrome. PCT/CRP ratio = PCT level (ng/mL)/CRP level (mg/dL). Data for the FS and AESD groups are from this study; other data is from Nakanishi et al. Figure 2 PCT/CRP ratio in FS and AESD. AESD: acute encephalopathy with biphasic seizures and late reduced diffusion; CRP: C-reactive protein; FS, febrile seizures; PCT: procalcitonin. PCT/CRP ratio = PCT level (ng/mL)/CRP level (mg/dL). Figure 3 Time course of PCT and CRP after onset in AESD. CRP: C-reactive protein; mPSL pulse: methyl prednisolone pulse therapy; PCT: procalcitonin. Follow-up after diagnosis of acute encephalopathy with biphasic seizures and late reduced diffusion and start of intervention. Data are presented as the mean ± standard deviation. Table 1 Patient characteristics of AESD and FS. AESD: acute encephalopathy with biphasic seizures and late reduced diffusion; FS: febrile seizures; HHV-6: human herpesvirus-6; hMPV: human metapneumovirus. ∗All AESD specimens were subjected to blood culture, and results were all negative. Table 2 PCT, CRP, and inflammatory cytokine of AESD and FS. AESD: acute encephalopathy with biphasic seizures and late reduced diffusion; CRP: C-reactive protein; FS: febrile seizures; PCT: procalcitonin. Data are presented as the mean ± standard deviation. ∗The ratio was calculated using a CRP value of 0.15 when it is below 0.15.
  1 in total

1.  Serum Procalcitonin Levels in Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion.

Authors:  Yosuke Fujii; Masato Yashiro; Mutsuko Yamada; Tomonobu Kikkawa; Nobuyuki Nosaka; Yukie Saito; Kohei Tsukahara; Masanori Ikeda; Tsuneo Morishima; Hirokazu Tsukahara
Journal:  Dis Markers       Date:  2018-03-14       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.